Successful mergers and acquisitions fueling growth
Over the past decade, many Utah life sciences start-ups have been successful in attracting private capital. This capital influx has fueled medical innovation and the rise of many new companies.
FINANCING TRANSACTIONS
| Company |
Amount (in Millions) |
Year |
| HealthEquity |
$90 |
2016 |
| Health Catalyst |
70 |
2016 |
| Recursion Pharmaceuticals |
60 |
2017 |
| Collective Medical Technology |
47.5 |
2016 |
| Great Basin Scientific |
42 |
2015 |
| Sera Prognostics |
40 |
2017 |
| Lipocine |
30 |
2015 |
| Clene Nanomedicine |
27 |
2015 |
| Weave Communications |
23 |
2016 |
| Silvervue |
18 |
2016 |
| Clene Nanomedicine |
17 |
2016 |
| LineaGen |
16 |
2015 |
| Owlet Baby Care |
15 |
2016 |
| Recursion Pharmaceuticals |
15 |
2016 |
| Amedica |
11 |
2016 |
| Wasatch Microfluidics |
10 |
2016 |
| Vital Access |
10 |
2015 |
| Artemis Health |
10 |
2016 |